4//SEC Filing
Schacterle Amy 4
Accession 0000950170-24-122484
CIK 0001576885other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:27 PM ET
Size
5.5 KB
Accession
0000950170-24-122484
Insider Transaction Report
Form 4
Schacterle Amy
Chief Regulatory Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-11-05+340,000→ 340,000 totalExercise: $2.95Exp: 2034-11-05→ Common Stock (340,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on November 5, 2025, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest and become exercisable each month thereafter, subject to Reporting Person continuing to provide service through each such date.
Documents
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0002042021
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 5:27 PM ET
- Size
- 5.5 KB